Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: US
  • Asset Class: Equity
  • Geographic Focus: U.S.

Natixis International Funds Lux I - Loomis Sayles US Research

+ Add to Watchlist

CDCUSIC:LX

197.83 EUR 0.09 0.05%

As of 09:30:00 ET on 05/21/2015.

Snapshot for Natixis International Funds Lux I - Loomis Sayles US Research (CDCUSIC)

Year To Date: +13.60% 3-Month: +3.38% 3-Year: +23.02% 52-Week Range: 146.00 - 206.38
1-Month: -2.35% 1-Year: +36.79% 5-Year: +18.62% Beta vs SPTR: 0.99

Mutual Fund Chart for CDCUSIC

No chart data available.
  • CDCUSIC:LX 197.83
  • 1M
  • 1Y
Interactive CDCUSIC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CDCUSIC

Natixis International Funds (Lux) I - Loomis Sayles US Research is an open-end Fund incorporated in Luxembourg. The Fund's objective is a maximum total return and long-term capital growth. The Fund invests at least 2/3 of its assets in US equity securities of large-capitalisation companies.

Inception Date: 01-21-2003 Telephone: +352-474-066-312
Managers: MAUREEN DEPP
Web Site: ga.natixis.com/global

Fundamentals for CDCUSIC

NAV (on 2015-05-21) 197.83
Assets (M) (on 2015-05-21) 741.69
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment -

Dividends for CDCUSIC

No dividends reported

Fees & Expenses for CDCUSIC

Front Load 4.00
Back Load 0.00
Current Mgmt Fee -
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.00

Top Fund Holdings for CDCUSIC

Filing Date: 03/31/2015
Name Position Value % of Total
Apple Inc 185,593 23,093,337 3.282%
Gilead Sciences Inc 173,348 17,010,639 2.418%
Actavis plc 54,445 16,203,921 2.303%
Visa Inc 235,382 15,396,337 2.188%
Wells Fargo & Co 265,816 14,460,390 2.055%
Exxon Mobil Corp 169,025 14,367,125 2.042%
UnitedHealth Group Inc 120,425 14,245,073 2.025%
Google Inc 25,445 14,114,342 2.006%
Google Inc 25,404 13,883,032 1.973%
JPMorgan Chase & Co 229,096 13,878,636 1.973%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil